Working to preserve the health of women and families since 1995.
- With the Ministry of Health, Jhpiego piloted and introduced cervical cancer prevention services at two university hospitals and subsequently expanded them to 12 additional sites with financial support from other organizations. From 2010 to 2014, 13,999 women screened for cervical cancer, 8.9% screened positive and 65.9% received cryotherapy in a single visit.
- Jhpiego also collaborated with the Ministry of Health to introduce and expand postpartum IUD (PPIUD) services, resulting in more than 300 health facilities across all 13 of the country’s regions now providing PPIUD to women who recently delivered and want to space their next pregnancy.
- From 2016 to 2018, the percentage of postpartum women adopting a family planning method increased from 25% to 55% and those who received PPFP counseling increased from 46% to 77%—resulting in 47,837 women delaying their pregnancy and 66,981 postpartum women counseled.
- From 2007 to 2011, 386,722 pregnant women received counseling and testing for HIV; of 4,070 women who tested positive and gave birth in health facilities, 91% received case management to prevent mother-to-child transmission of HIV. During the same period, the percentage of HIV-exposed infants testing positive for HIV decreased from 6% to 1.5%.
Our Work in Burkina Faso
Jhpiego is leading the five-year Improving Malaria Care project, funded by the U.S. Agency for International Development. The project provided technical assistance for the prevention, diagnosis and case management of malaria, with specific emphasis on malaria in pregnancy and in children under five, as well as on improving the National Malaria Control Program’s capacity. Through this project, Jhpiego aims to: 1) improve malaria prevention in support of the National Malaria Strategic Plan; 2) improve malaria diagnosis and treatment interventions in support of the National Malaria Strategic Plan; and 3) strengthen the National Malaria Control Program’s capacity to plan, design, manage and coordinate a comprehensive malaria control program. Under an additional award through this project, Jhpiego will provide technical assistance in infection prevention and control (IPC) to support the Ministry of Health to: 1) train frontline, public-sector health care workers on IPC; and 2) provide supportive supervision and coaching to improve IPC practices in health care services.
With funding from the U.S. Centers for Disease Control and Prevention, Jhpiego is supporting the prevention of antimicrobial resistance (AMR), an issue of increasing importance worldwide. The goal of the project is to improve local capacity to prevent, detect and effectively respond to infectious disease threats and prevent antimicrobial resistance. To reach this goal, Jhpiego is: 1) improving infection prevention and control at health facilities; 2) supporting development of a point prevalence of health care associated infections to strengthen referral and reporting systems across the health pyramid; and 3) supporting the tracking of antimicrobial use.
Under an initiative funded by a large anonymous donor, Jhpiego is strengthening pre-service education in Burkina Faso to increase the uptake of postpartum family planning (PPFP). This program aims to integrate PPFP into the pre-service education of midwives and obstetricians/gynecologists. Jhpiego is also providing innovative ways such as mobile mentoring (mMentoring) to keep new graduates and providers engaged with the information learned. Simultaneously, Jhpiego is also providing postpartum family planning counseling and family planning methods to women.
This three-year project, funded by the Bill & Melinda Gates Foundation, seeks to uphold the quality of contraceptive implant services by working at the global and country levels. Globally, Jhpiego serves in a technical advisory role for the Implant Access Program’s Operations Group—a working group comprised of donor representatives that supports quality implant programs—to monitor, identify and collaboratively respond to priority issues. Jhpiego also provides short-term technical assistance to ensure that several countries with high implant use, including Burkina Faso, incorporate a quality implant removal component into overall implant strategy and implementation.
This four-year project, funded by the Bill & Melinda Gates Foundation, builds on the PMA2020 project, which used innovative mobile technology to support low-cost, rapid-turnaround surveys monitoring key health and development indicators. PMA is enhancing this survey platform to generate high-quality data and ensure that governments, donors, managers and advocates use this data to make decisions regarding family planning programs. In addition to scaling up the survey platform for more widespread use, this project supports expanding it to include additional technical areas. Co-led by Jhpiego and the Bill & Melinda Gates Institute for Population and Reproductive Health, this project is operational in several African and Asian countries, including Burkina Faso.
Funded by the Bill & Melinda Gates Foundation, this program promotes access to family planning choices in West African countries by supporting the introduction and scale-up of subcutaneous depot-medroxyprogesterone acetate (DMPA-SC). DMPA-SC is an innovative injectable contraceptive—also known as Sayana® Press—that can dramatically expand access and choice for women. Jhpiego is enhancing ongoing efforts of the Access Collaborative by strengthening health systems to accelerate introduction and scale-up of DMPA-SC in several West African countries, including Burkina Faso.